Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 3:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 3
2 (100.0%)Clinical Endpoint Bioequivalence Study of Test and Reference Inhalation Products in Patients With COPD With Device Robustness
Phase 3
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Drug: Reference Product (Spiriva®)Drug: Test Product (tiotropium bromide inhalation powder)Drug: Placebo
- First Posted Date
- 2017-05-03
- Last Posted Date
- 2021-04-05
- Lead Sponsor
- Lupin, Inc.
- Target Recruit Count
- 377
- Registration Number
- NCT03137992
- Locations
- 🇺🇸
Investigational Research Center Site #1017, Andalusia, Alabama, United States
🇺🇸Investigational Research Center Site #1003, Jasper, Alabama, United States
🇺🇸Investigational Research Center Site #1008, Glendale, Arizona, United States
Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma
Phase 3
Completed
- Conditions
- Mild Persistent Asthma
- Interventions
- Other: methacholine chlorideDrug: placebo ProAir HFA
- First Posted Date
- 2015-10-22
- Last Posted Date
- 2020-12-04
- Lead Sponsor
- Lupin, Inc.
- Target Recruit Count
- 217
- Registration Number
- NCT02584257
- Locations
- 🇺🇸
Investigational Research Center Site #110, Huntington Beach, California, United States
🇺🇸Investigational Research Center Site #114, Mission Viejo, California, United States
🇺🇸Investigational Research Center Site #113, Rolling Hills Estates, California, United States
News
No news found